Connection

DARYL SHORTER to Humans

This is a "connection" page, showing publications DARYL SHORTER has written about Humans.
Connection Strength

0.161
  1. Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant. Am J Drug Alcohol Abuse. 2020; 46(2):184-193.
    View in: PubMed
    Score: 0.019
  2. Adolescent Addiction Curriculum: Impact on Knowledge Self-Assessment in Pediatric Learners. MedEdPORTAL. 2018 05 07; 14:10716.
    View in: PubMed
    Score: 0.017
  3. The a-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenet Genomics. 2016 09; 26(9):428-35.
    View in: PubMed
    Score: 0.015
  4. Pharmacologic management of comorbid post-traumatic stress disorder and addictions. Am J Addict. 2015 Dec; 24(8):705-12.
    View in: PubMed
    Score: 0.014
  5. Needs assessment survey of addictions training in general psychiatry residency. Am J Addict. 2015 Apr; 24(3):191-192.
    View in: PubMed
    Score: 0.013
  6. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opin Emerg Drugs. 2015 Mar; 20(1):15-29.
    View in: PubMed
    Score: 0.013
  7. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and a1A-adrenoceptor gene variation. Eur Neuropsychopharmacol. 2013 Nov; 23(11):1401-7.
    View in: PubMed
    Score: 0.012
  8. The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):66-70.
    View in: PubMed
    Score: 0.011
  9. Addiction training in general psychiatry residency: a national survey. Subst Abus. 2012; 33(4):392-4.
    View in: PubMed
    Score: 0.011
  10. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med. 2011 Nov 03; 9:119.
    View in: PubMed
    Score: 0.011
  11. Treating Alcohol Use Disorder in U.S. Veterans: The Role of Traumatic Brain Injury. J Neuropsychiatry Clin Neurosci. 2019; 31(4):319-327.
    View in: PubMed
    Score: 0.004
  12. Pharmacogenetics of Dopamine ?-Hydroxylase in cocaine dependence therapy with doxazosin. Addict Biol. 2019 05; 24(3):531-538.
    View in: PubMed
    Score: 0.004
  13. Current status and future prospects for the development of substance abuse vaccines. Expert Rev Vaccines. 2017 11; 16(11):1067-1077.
    View in: PubMed
    Score: 0.004
  14. Update on pharmacotherapy for treatment of opioid use disorder. Expert Opin Pharmacother. 2016 Dec; 17(17):2307-2318.
    View in: PubMed
    Score: 0.004
  15. Buprenorphine Prescribing: To Expand or Not to Expand. J Psychiatr Pract. 2016 05; 22(3):183-92.
    View in: PubMed
    Score: 0.004
  16. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opin Pharmacother. 2014 Oct; 15(15):2263-75.
    View in: PubMed
    Score: 0.003
  17. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014 Jul 01; 140:42-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.